About us

Vision & Mission

C4Diagnostics is developing in vitro diagnostics kits based on its proprietary technology, with the following specifications in mind:

Simple for the lab, fast and accurate for the patient and the medical community: actionable medical information for medical professionals.

C4Diagnostics aims at disrupting the global market of infectious diseases IVD by:

  • Delivering faster highly sensitive results
  • Addressing unmet medical needs

C4Diagnostics develops and commercializes IVD kits based on its proprietary, versatile, phenotypic and simple technology.

History

April 2020 : Implementation and coordination of COMETE (Covid-19 Marseille Environnemental Testing)
COMETE (Covid-19 Marseille Environnemental Testing)

December 2019 : Series A Fundraising € 2.3 Millions
Fundraising 2019 of C4Diagnostics

September 2019 : C4Legio™ available
September 2019 : C4Legio™ available

March 2019 : execution of key distribution agreements
Map of the distributors of C4Diagnostics' products

January 2019 : ISO 13485 certification
January 2019 : ISO 13485 certification

Spring 2018 : Fundraising €1.5 Million
Spring 2018 : Fundraising €1.5 Million

May 2017 : inception of C4Diagnostics
May 2017 : inception of C4Diagnostics

Our Commitments

ISO 13485 standards

C4Diagnostics commits to deliver accurate medical information with products designed and manufactured according to the highest standards.

Lloyd’s Registrer (Notified Body) ISO 13485:2016 certified C4Dx in January 2019

Team

C4Diagnostics’ management team has significant and complementary experience in the development, implementation, and commercialization of infectious diseases in vitro diagnostics.

Today, the C4Diagnostics’ team includes 11 full time jobs and 3 part-time jobs.

Heads of

Younes Lazrak

Younes Lazrak

Founder & CEO

Before cofounding C4Diagnostics, Younes worked in Business Development and IP management in several in vitro diagnostics companies (Incl. Ipsogen & Qiagen), with an impressive track record. His main responsibilities were Licensing in & out and the management of the industrial intellectual ownership, before progressively shifting to Business development and alliances management.

Damien Thomas

Damien Thomas

Head of R&D and Industrialization

After a PhD in microbiology and immunology, Damien has worked in different IVD private companies. For Ingen/Eurobio, Damien was in charge of R&D and Industrialization teams. Then, he managed the Manufacturing, Quality Control, Logistic team’s for Theradiag and Operation management for IDS. He joined in the summer 2019 C4Diagnostics as Head of R&D and Industrialization.

Thierry Maunier

Thierry Maunier

Head of Quality & Regulatory Affairs

Quality Engineer & M.Sc. in Microbiology and Immunology, Thierry served as Quality Assurance and Quality Control Manager in various Medical Device design and manufacturing companies. Quality Systems he implemented and managed have efficiently fulfilled international standards (ISO13485, ISO9001) & International Regulation requirements (MDR, MDIVD, 21CFRs, SOR).

Saïd Jamal

Saïd Jamal

Head of Projects & Operations

With dual managerial and scientific expertise, Saïd has mainly evolved in the life sciences sector (CNRS, Galderma R&D, GSK, etc.) as Project Leader. He joined the team in January 2018 and he is now heading Operations & Projects to structure manufacturing, manage external industrial partners relationships and support all the projects of the company.

Board

Émilie Fugier

Émilie Fugier

Founder & R&D Team Leader / Board member

PhD in microbiology and immunology, Emilie has managed various scientific projects involving different pathogenic organisms with industries (CHEMUNEX) and hospitals (CHU Grenoble, Hôpital St-Joseph Marseille). In 2012, she joined Sam Dukan’s team in the CNRS to work on the technology used by C4Diagnostics. She is now collaborating on all R&D projects.

Sam Dukan

Sam Dukan

Founder, Scientific Advisor & Board Member

Former student of the Ecole Normale Supérieure in Paris, then research director leading a team of up to 12 people in CNRS (National Center of Scientifical research), Sam has worked during his all career within big groups like Suez Environnement or CIBA, on application challenges, witnessing technical and operationnal adaptability. Author of 45 scientific publications and co-inventor of 8 patents, Sam is scientifically advising the C4Diagnostics’ projects. He is also the CEO of Diamidex.

Hélène PEYRO-ST-PAUL

Medical Affairs

Medical Affairs – 20+ years exp.

Independant (former Qiagen, EMD Serono)

Amine BOUKOUSS

Board member

Investment and growth capital – 5 years exp.

Associate (Turenne Capital)

Oriane BURLAT

Board member

Finance – 10 years exp.

Manager in Investment Department (ACG Management)

Jean-François GRENIER

Market Access

Strategy advisor – 25+ years exp.

Angels santé (former Bayer, Bristol-Myers Squib)

Pierre CHAVAGNE

Board member

Accounting management – 20+ years exp.

General Manager (Cisbio Bioassays)

Andrei POLUKHTIN

Board member

 

Managing Director (Click Chemistry Tools)

Armand PERRIN

Board member

FInance – 30+ years exp.

Investment Manager (CAAP Création)

PARTNERS